Skip to main content

Table 3 Studies presenting data on High-volume Image-guided Injection (HVIGI)

From: The effect of high-volume image-guided injection in the chronic non-insertional Achilles tendinopathy: a retrospective case series

 

Pts (n)

Age (y)

DoS (wk)

Post (wk)

US Δ (mm)

VISA-A pre

VISA-A post

VISA-A Δ

ET failed

Chan [11] (2008)

30

37

36

30

/

44 ± 18

76 ± 25

32

YES

Humphrey [16] (2010)

11

44

220

3

1.1

46 ± 15

84 ± 11

38

YES

Resteghini [17] (2012)

32

40

73

12

2.7

37

66

29

YES

Maffulli [18] (2013)

94

38

57

52

1.8

42 ± 23

75 ± 21

33

YES

Wheeler [19] (2014)

16

53

31

52

/

31 ± 22

72 ± 26

41

YES

Wheeler [20] (2016)

18

53

/

40

/

30 ± 21

64 ± 28

33

/

Abdulhussein [21] (2017)

12

46

13

52

/

43 ± 9

83 ± 12

40

YES

Boesen [9] (2017)

19

42

25

24

1.1

53

75

22

NO

Boesen [22] (2019)

14

43

44

24

1.2

52 ± 14

78 ± 5

26

NO

  1. VISA-A are presented as mean-values with standard deviation (±SD). Pts patients, DoS Duration of symptoms, Post Latest follow-up, US tendon thickness between baseline and Latest follow-up, Δ = improvement from pre to post, ET failed = ET failed before HVIGI, /=unknown